These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16982690)

  • 1. Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes.
    Potla R; Koeck T; Wegrzyn J; Cherukuri S; Shimoda K; Baker DP; Wolfman J; Planchon SM; Esposito C; Hoit B; Dulak J; Wolfman A; Stuehr D; Larner AC
    Mol Cell Biol; 2006 Nov; 26(22):8562-71. PubMed ID: 16982690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Atlantic salmon protein tyrosine kinase Tyk2: molecular cloning, modulation of expression and function.
    Sobhkhez M; Hansen T; Iliev DB; Skjesol A; Jørgensen JB
    Dev Comp Immunol; 2013 Dec; 41(4):553-63. PubMed ID: 23872231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Tyk2 and Stat3 is required for the apoptotic actions of interferon-beta in primary pro-B cells.
    Gamero AM; Potla R; Wegrzyn J; Szelag M; Edling AE; Shimoda K; Link DC; Dulak J; Baker DP; Tanabe Y; Grayson JM; Larner AC
    J Biol Chem; 2006 Jun; 281(24):16238-44. PubMed ID: 16601124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid.
    Kim HJ; Tsoyi K; Heo JM; Kang YJ; Park MK; Lee YS; Lee JH; Seo HG; Yun-Choi HS; Chang KC
    J Pharmacol Exp Ther; 2007 Feb; 320(2):782-9. PubMed ID: 17108235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase 2 interacts with the proapoptotic protein Siva-1 and augments its apoptotic functions.
    Shimoda HK; Shide K; Kameda T; Matsunaga T; Shimoda K
    Biochem Biophys Res Commun; 2010 Sep; 400(2):252-7. PubMed ID: 20727854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of catalytically active Tyk2 and accessory signals for the induction of TRAIL mRNA by IFN-beta.
    Rani MR; Pandalai S; Shrock J; Almasan A; Ransohoff RM
    J Interferon Cytokine Res; 2007 Sep; 27(9):767-79. PubMed ID: 17892398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance.
    Simma O; Zebedin E; Neugebauer N; Schellack C; Pilz A; Chang-Rodriguez S; Lingnau K; Weisz E; Putz EM; Pickl WF; Felzmann T; Müller M; Decker T; Sexl V; Stoiber D
    Cancer Res; 2009 Jan; 69(1):203-11. PubMed ID: 19118004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.
    Watling D; Guschin D; Müller M; Silvennoinen O; Witthuhn BA; Quelle FW; Rogers NC; Schindler C; Stark GR; Ihle JN
    Nature; 1993 Nov; 366(6451):166-70. PubMed ID: 7901766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An important role of Tyk2 in APC function of dendritic cells for priming CD8+ T cells producing IFN-gamma.
    Aizu K; Li W; Yajima T; Arai T; Shimoda K; Nimura Y; Yoshikai Y
    Eur J Immunol; 2006 Nov; 36(11):3060-70. PubMed ID: 17048270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock.
    Karaghiosoff M; Steinborn R; Kovarik P; Kriegshäuser G; Baccarini M; Donabauer B; Reichart U; Kolbe T; Bogdan C; Leanderson T; Levy D; Decker T; Müller M
    Nat Immunol; 2003 May; 4(5):471-7. PubMed ID: 12679810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hapten-induced contact hypersensitivity is enhanced in Tyk2-deficient mice.
    Hosogi M; Tonogaito H; Aioi A; Hamada K; Shimoda K; Muromoto R; Matsuda T; Miyachi Y
    J Dermatol Sci; 2004 Oct; 36(1):51-6. PubMed ID: 15488705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ-specific and differential requirement of TYK2 and IFNAR1 for LPS-induced iNOS expression in vivo.
    Painz R; Walter I; Kolbe T; Rigler D; Vogl C; Steinborn R; Rülicke T; Helmreich M; Karaghiosoff M; Müller M
    Immunobiology; 2007; 212(9-10):863-75. PubMed ID: 18086385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyk2 is essential for IFN-alpha-induced gene expression in mast cells.
    Mori Y; Hirose K; Suzuki K; Nakajima H; Seto Y; Ikeda K; Shimoda K; Nakayama K; Saito Y; Iwamoto I
    Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():25-9. PubMed ID: 15166480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TYK2 kinase activity is required for functional type I interferon responses in vivo.
    Prchal-Murphy M; Semper C; Lassnig C; Wallner B; Gausterer C; Teppner-Klymiuk I; Kobolak J; Müller S; Kolbe T; Karaghiosoff M; Dinnyés A; Rülicke T; Leitner NR; Strobl B; Müller M
    PLoS One; 2012; 7(6):e39141. PubMed ID: 22723949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myxoma virus selectively disrupts type I interferon signaling in primary human fibroblasts by blocking the activation of the Janus kinase Tyk2.
    Wang F; Barrett JW; Shao Q; Gao X; Dekaban GA; McFadden G
    Virology; 2009 Apr; 387(1):136-46. PubMed ID: 19254804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent.
    Li Z; Gakovic M; Ragimbeau J; Eloranta ML; Rönnblom L; Michel F; Pellegrini S
    J Immunol; 2013 Mar; 190(5):2335-44. PubMed ID: 23359498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutant form of p135tyk2, an interferon-alpha inducible tyrosine kinase, suppresses the transformed phenotype of Daudi cells.
    Davis E; Krishnan K; Yan H; Newcomb EW; Krolewski JJ
    Leukemia; 1996 Mar; 10(3):543-51. PubMed ID: 8642873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine kinase 2 modulates splenic B cells through type I IFN and TLR7 signaling.
    Bodega-Mayor I; Delgado-Wicke P; Arrabal A; Alegría-Carrasco E; Nicolao-Gómez A; Jaén-Castaño M; Espadas C; Dopazo A; de Luis EV; Martín-Gayo E; Gaspar ML; de Andrés B; Fernández-Ruiz E
    Cell Mol Life Sci; 2024 Apr; 81(1):199. PubMed ID: 38683377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
    Bright JJ; Sriram S
    J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
    Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
    Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.